|
1
|
Fontenot HB and Harris AL: Pharmacologic
management of osteoporosis. J Obstet Gynecol Neonatal Nurs.
43:236–245; quiz E20-E21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cosman F, de Beur SJ, LeBoff MS, Lewiecki
EM, Tanner B, Randall S and Lindsay R: Erratum to: Clinician's
guide to prevention and treatment of osteoporosis. Osteoporos Int.
26:2045–2047. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Caplan AI: Review: mesenchymal stem cells:
cell-based reconstructive therapy in orthopedics. Tissue Eng.
11:1198–1211. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Augello A and De Bari C: The regulation of
differentiation in mesenchymal stem cells. Hum Gene Ther.
21:1226–1238. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kanis JA, Burlet N, Cooper C, Delmas PD,
Reginster JY, Borgstrom F and Rizzoli R: European Society for
Clinical Economic Aspects of Osteoporosis Osteoarthritis (ESCEO)
European guidance for the diagnosis and management of osteoporosis
in postmenopausal women. Osteoporos Int. 19:399–428. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Watanabe K and Ikeda K: Osteocytes in
normal physiology and osteoporosis. Clin Rev Bone Miner Metab.
8:224–232. 2010. View Article : Google Scholar
|
|
7
|
Harada H, Tagashira S, Fujiwara M, Ogawa
S, Katsumata T, Yamaguchi A, Komori T and Nakatsuka M: Cbfa1
isoforms exert functional differences in osteoblast
differentiation. J Biol Chem. 274:6972–6978. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hanai J, Chen LF, Kanno T, Ohtani-Fujita
N, Kim WY, Guo WH, Imamura T, Ishidou Y, Fukuchi M, Shi MJ, et al:
Interaction and functional cooperation of PEBP2/CBF with Smads.
Synergistic induction of the immunoglobulin germline Calpha
promoter. J Biol Chem. 274:31577–31582. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
López-Giménez MR and García Gómez JJ: The
Fisher's test. Med Clin (Barc). 101:156–157. 1993.(In Spanish).
PubMed/NCBI
|
|
10
|
Stojanova D, Ceci M, Malerba D and
Dzeroski S: Using PPI network autocorrelation in hierarchical
multi-label classification trees for gene function prediction. BMC
Bioinformatics. 14:2852013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luu YK, Capilla E, Rosen CJ, Gilsanz V,
Pessin JE, Judex S and Rubin CT: Mechanical stimulation of
mesenchymal stem cell proliferation and differentiation promotes
osteogenesis while preventing dietary-induced obesity. J Bone Miner
Res. 24:50–61. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun D, Junger WG, Yuan C, Zhang W, Bao Y,
Qin D, Wang C, Tan L, Qi B, Zhu D, et al: Shockwaves induce
osteogenic differentiation of human mesenchymal stem cells through
ATP release and activation of P2X7 receptors. Stem Cells.
31:1170–1180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hess J, Angel P and Schorpp-Kistner M:
AP-1 subunits: Quarrel and harmony among siblings. J Cell Sci.
117:5965–5973. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pham DN, Luo H and Wu J: Reduced Ran
expression in Ran(+/−) fibroblasts increases cytokine-stimulated
nuclear abundance of the AP-1 subunits c-Fos and c-Jun. FEBS Lett.
584:4623–4626. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stöckl S, Göttl C, Grifka J and Grässel S:
Sox9 modulates proliferation and expression of osteogenic markers
of adipose-derived stem cells (ASC). Cell Physiol Biochem.
31:703–717. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Loebel C, Czekanska EM, Bruderer M,
Salzmann G, Alini M and Stoddart MJ: In vitro osteogenic potential
of human mesenchymal stem cells is predicted by Runx2/Sox9 ratio.
Tissue Eng Part A. 21:115–123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu Z, Wang Y, Sun Z, Wang H, Zhou H, Zhang
L, Zhang S and Cao X: miRNA-132-3p inhibits osteoblast
differentiation by targeting Ep300 in simulated microgravity. Sci
Rep. 5:186552015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei J, Shimazu J, Makinistoglu MP, Maurizi
A, Kajimura D, Zong H, Takarada T, Lezaki T, Pessin JE, Hinoi E, et
al: Glucose uptake and Runx2 synergize to orchestrate osteoblast
differentiation and bone formation. Cell. 161:1576–1591. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Okuda T, van Deursen J, Hiebert SW,
Grosveld G and Downing JR: AML1, the target of multiple chromosomal
translocations in human leukemia, is essential for normal fetal
liver hematopoiesis. Cell. 84:321–330. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Soung do Y, Kalinowski J, Baniwal SK,
Jacome-Galarza CE, Frenkel B, Lorenzo J and Drissi H:
Runx1-mediated regulation of osteoclast differentiation and
function. Mol Endocrinol. 28:546–553. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saito T, Ohba S, Yano F, Seto I, Yonehara
Y, Takato T and Ogasawara T: Runx1 and Runx3 are downstream
effectors of Nanog in promoting osteogenic differentiation of the
mouse mesenchymal cell line C3H10T1/2. Cell Reprogram. 17:227–234.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pan H, Li X, Wang J, Zhang K, Yang H, Li
Z, Zheng Z and Liu H: LIM mineralization protein-1 enhances bone
morphogenetic protein-2-mediated osteogenesis through activation of
ERK1/2 MAPK pathway upregulation of Runx2 transactivity. J Bone
Miner Res. 30:1523–1535. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bauer O, Sharir A, Kimura A, Hantisteanu
S, Takeda S and Groner Y: Loss of osteoblast Runx3 produces severe
congenital osteopenia. Mol Cell Biol. 35:1097–1109. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wigner NA, Soung Y, Einhorn TA, Drissi H
and Gerstenfeld LC: Functional role of Runx3 in the regulation of
aggrecan expression during cartilage development. J Cell Physiol.
228:2232–2242. 2013. View Article : Google Scholar : PubMed/NCBI
|
